Oscar Health (OSCR) Invested Capital (2020 - 2026)

Oscar Health has reported Invested Capital for 7 years, with the latest figure at $2.1 billion in Q1 2026.

• For the quarter ending Q1 2026, Invested Capital rose 26.01% year-over-year to $2.1 billion; the trailing twelve-month figure through Mar 2026 stood at $2.1 billion (up 26.01% YoY), and the FY2025 full-year result was $1.4 billion, up 358.78% from the prior year.
• Invested Capital for Q1 2026 stood at $2.1 billion, up from $1.4 billion in the prior quarter.
• The five-year high for Invested Capital was $4.1 billion in Q2 2024, with the low at -$2.4 billion in Q1 2024.
• Historically, Invested Capital has averaged $1.1 billion across 5 years, with a median of $1.3 billion in 2025.
• The largest YoY upside for Invested Capital was 1282.88% in 2024 against a maximum downside of 295.16% in 2024.
• Oscar Health's Invested Capital stood at $298.0 million in 2022, then surged by 270.78% to $1.1 billion in 2023, then plunged by 72.89% to $299.6 million in 2024, then jumped by 358.78% to $1.4 billion in 2025, then soared by 49.99% to $2.1 billion in 2026.
• The last three Invested Capital figures came in at $2.1 billion (Q1 2026), $1.4 billion (Q4 2025), and $1.3 billion (Q3 2025), per Business Quant data.